At meeting held on 25 March 2019
The Board of Krebs Biochemicals & Industries at its meeting held on 25 March 2019 has approved the allotment of 28,86,300 equity shares as per the basis of allotment approved by BSE (the Designated Stock Exchange) on 22 March 2019. Further, the paid-up equity share capital of the Company amounts to Rs. 16,63,05,860/- divided into 1,66,30,586 equity shares of Rs. 10/- each.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
